Zevra Therapeutics, Inc. ZVRA Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s total cost of revenue?
- Zevra Therapeutics, Inc. (ZVRA) reported total cost of revenue of $1.9M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s total cost of revenue changed year-over-year?
- Zevra Therapeutics, Inc.'s total cost of revenue increased by 41.0% year-over-year, from $1.35M to $1.9M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s total cost of revenue has grown at a 68.2% compound annual growth rate (CAGR), from $2.06M to $16.48M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.